Breaking News Instant updates and real-time market news.

DVAX

Dynavax

06:27
07/31/17
07/31
06:27
07/31/17
06:27

Dynavax upgraded to Outperform from Sector Perform at RBC Capital

  • 31

    Jul

  • 10

    Aug

DVAX Dynavax

07/31/17
JPMS
07/31/17
UPGRADE
Target $27
JPMS
Overweight
Dynavax upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Dynavax to Overweight and raised his price target for the shares to $27 from $6. Following last week's FDA panel, the analyst now believes that hepatitis B vaccine Heplisav has a high probability of approval by the August 10 action date. He expects "rapid uptake" and sees $450M-plus in peak sales in the U.S. alone. Further, Rama believes SD-101 has compelling early-stage data in treatment-naive melanoma. The analyst views the asset as underappreciated.
11/15/16
WBLR
11/15/16
NO CHANGE
Target $17
WBLR
Outperform
William Blair still sees 'good chance' for approval of Dynavax's Heplisav
William Blair analyst Y. Katherine Xu lowered her price target for Dynavax Technologies to $17 from $45 after the company received a second Complete Response Letter from the FDA for the Heplisav Biologics License Application. There is still a "good chance" for Heplisav to garner eventual approval, Xu tells investors in a research note. The lack of apparent concerns regarding rare serious autoimmune events is a plus, the analyst contends. Xu keeps an Outperform rating on Dynavax. She points out the company's immuno-oncology program SD-101 is reading out substantial data starting in 2017. Dynavax closed yesterday down 65% to $4.10.
11/14/16
COWN
11/14/16
NO CHANGE
Target $45
COWN
Outperform
Dynavax's Heplisav may still have a path forward, says Cowen
Cowen analyst Phil Nadeau called the CRL issued to Dynavax regarding its Biologics License Application for Heplisav-B "disappointing and concerning," but also noted that the FDA did not request new trials. While the CRL will push approval until late 2017, in a best case scenario, there may still be a path forward for approval of the drug, said Nadeau, who added that he thinks the stock now looks undervalued. The analyst has an Outperform rating and $45 price target on Dynavax shares.
09/06/16
WBLR
09/06/16
NO CHANGE
WBLR
Outperform
FDA panel cancelation positive for Dynavax, says William Blair
William Blair analyst Y. Katherine Xu views the FDA's decision to canceled the November 16 Vaccines and Related Biological Products Advisory Committee meeting for Heplisav as a net positive for Dynavax. The agency's decision to move straight to the PDUFA date suggests that the Heplisav package is "sufficiently strong and adequate to warrant approval in the absence of a panel," Xu tells investors in a research note. She keeps an Outperform rating on Dynavax. The stock is up 19% to $13.00 in pre-market trading.

TODAY'S FREE FLY STORIES

INFY

Infosys

$14.79

-1.14 (-7.16%)

04:04
08/21/17
08/21
04:04
08/21/17
04:04
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 06

    Sep

CPN

Calpine

$14.92

1.42 (10.52%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Downgrade
Calpine rating change  »

Calpine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$105.92

7.6 (7.73%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Upgrade
Estee Lauder rating change  »

Estee Lauder upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOC

Physicians Realty Trust

$17.94

-0.24 (-1.32%)

04:01
08/21/17
08/21
04:01
08/21/17
04:01
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBMD

Howard Bancorp

$18.05

0.65 (3.74%)

03:58
08/21/17
08/21
03:58
08/21/17
03:58
Upgrade
Howard Bancorp rating change  »

Howard Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SNA

Snap-On

$147.96

-0.86 (-0.58%)

03:56
08/21/17
08/21
03:56
08/21/17
03:56
Downgrade
Snap-On rating change  »

Snap-On downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 06

    Sep

E

Eni SpA

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Eni SpA rating change  »

Eni SpA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$18.41

0.31 (1.71%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Statoil rating change  »

Statoil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Repsol rating change  »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$50.49

0.61 (1.22%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Total rating change  »

Total downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$16.63

0.23 (1.40%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Canadian Solar rating change  »

Canadian Solar downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

03:43
08/21/17
08/21
03:43
08/21/17
03:43
Upgrade
Advance Auto Parts rating change  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$22.53

-0.22 (-0.97%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
At Home Group initiated  »

At Home Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWW

Grainger

$161.39

-3.21 (-1.95%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
Grainger initiated  »

Grainger reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Jan

NKE

Nike

$54.95

-2.51 (-4.37%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Downgrade
Nike rating change  »

Nike downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

03:40
08/21/17
08/21
03:40
08/21/17
03:40
General news
FX Action: USD-CAD has settled near 1.2600 »

FX Action: USD-CAD has…

03:05
08/21/17
08/21
03:05
08/21/17
03:05
General news
FX Update: The dollar majors traded without drama »

FX Update: The dollar…

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:25
08/20/17
08/20
20:25
08/20/17
20:25
Earnings
Notable company reporting before Monday's open »

The notable company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:16
08/20/17
08/20
20:16
08/20/17
20:16
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q3 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:11
08/20/17
08/20
20:11
08/20/17
20:11
Earnings
58.com reports Q2 EPS 55c, consensus 20c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

, LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

20:02
08/20/17
08/20
20:02
08/20/17
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

BGS

B&G Foods

$31.40

-0.3 (-0.95%)

MDLZ

Mondelez

$42.94

-0.47 (-1.08%)

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

  • 06

    Sep

  • 11

    Sep

  • 14

    Sep

  • 18

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Sep

  • 29

    Sep

  • 02

    Nov

  • 25

    Jan

SRE

Sempra Energy

$116.55

0.76 (0.66%)

, BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

18:47
08/20/17
08/20
18:47
08/20/17
18:47
Periodicals
Sempra Energy near deal to acquire Oncor Electric, Bloomberg reports »

Sempra Energy (SRE) is…

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

TWX

Time Warner

$101.19

-0.42 (-0.41%)

, CMCSA

Comcast

$40.52

0.25 (0.62%)

18:34
08/20/17
08/20
18:34
08/20/17
18:34
Hot Stocks
Box Office Battle: 'Hitman's Bodyguard' wins weekend with $21.6M »

Lionsgate' (LGF.A)…

TWX

Time Warner

$101.19

-0.42 (-0.41%)

CMCSA

Comcast

$40.52

0.25 (0.62%)

CMCSK

Comcast

SNE

Sony

$38.77

-0.23 (-0.59%)

FOX

21st Century Fox

$26.79

-0.1 (-0.37%)

FOXA

21st Century Fox

$27.26

-0.09 (-0.33%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

DIS

Disney

$100.70

-0.68 (-0.67%)

VIAB

Viacom

$28.59

-0.62 (-2.12%)

VIA

Viacom

$38.80

-3.6 (-8.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

GME

GameStop

$21.22

0.12 (0.57%)

, MSFT

Microsoft

$72.49

0.09 (0.12%)

17:08
08/20/17
08/20
17:08
08/20/17
17:08
Hot Stocks
GameStop kicks off nationwide pre-orders for Microsoft Xbox One X »

GameStop (GME) is…

GME

GameStop

$21.22

0.12 (0.57%)

MSFT

Microsoft

$72.49

0.09 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

GS

Goldman Sachs

$222.15

0.73 (0.33%)

16:48
08/20/17
08/20
16:48
08/20/17
16:48
Periodicals
Goldman Sachs receives approval to trade equities in Saudi Arabia, Reuters says »

Goldman Sachs has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.